Analyst Ratings for Caris Life Sciences Inc (CAI)
CAI Rating Summary
CAI Price Target Summary
- Highest: $36.00 (TD Cowen)
- Lowest: $21.00 (Piper Sandler)
- Average: $29.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$29.00 (-5.1%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/9/2026 | UBS | Douglas Schenkel | New Coverage | Neutral (N/A) |
28.00 (N/A) |
24.82 (30.56) |
23.13% | Details |
| 7/30/2026 | Citi | Brendan Digan | New Coverage | Buy (N/A) |
28.00 (N/A) |
15.59 (30.56) |
96.02% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
